Instant labeling of therapeutic cells for multimodality imaging

Autologous therapeutic cells are typically harvested and transplanted in one single surgery. This makes it impossible to label them with imaging biomarkers through classical transfection techniques in a laboratory. To solve this problem, we developed a novel microfluidic device, which provides highly efficient labeling of therapeutic cells with imaging biomarkers through mechanoporation. Methods: Studies were performed with a new, custom-designed microfluidic device, which contains ridges, which compress adipose tissue-derived stem cells (ADSCs) during their device passage. Cell relaxation after compression leads to cell volume exchange for convective transfer of nanoparticles and nanoparticle uptake into the cell. ADSCs were passed through the microfluidic device doped with iron oxide nanoparticles and 18F-fluorodeoxyglucose (FDG). The cellular nanoparticle and radiotracer uptake was evaluated with DAB-Prussian blue, fluorescent microscopy, and inductively coupled plasma spectrometry (ICP). Labeled and unlabeled ADSCs were imaged in vitro as well as ex vivo in pig knee specimen with magnetic resonance imaging (MRI) and positron emission tomography (PET). T2 relaxation times and radiotracer signal were compared between labeled and unlabeled cell transplants using Student T-test with p<0.05. Results: We report significant labeling of ADSCs with iron oxide nanoparticles and 18F-FDG within 12+/-3 minutes. Mechanoporation of ADSCs with our microfluidic device led to significant nanoparticle (> 1 pg iron per cell) and 18F-FDG uptake (61 mBq/cell), with a labeling efficiency of 95%. The labeled ADSCs could be detected with MRI and PET imaging technologies: Nanoparticle labeled ADSC demonstrated significantly shorter T2 relaxation times (24.2±2.1 ms) compared to unlabeled cells (79.6±0.8 ms) on MRI (p<0.05) and 18F-FDG labeled ADSC showed significantly higher radiotracer uptake (614.3 ± 9.5 Bq / 1×104 cells) compared to controls (0.0 ± 0.0 Bq/ 1×104 cells) on gamma counting (p<0.05). After implantation of dual-labeled ADSCs into pig knee specimen, the labeled ADSCs revealed significantly shorter T2 relaxation times (41±0.6 ms) compared to unlabeled controls (90±1.8 ms) (p<0.05). Conclusion: The labeling of therapeutic cells with our new microfluidic device does not require any chemical intervention, therefore it is broadly and immediately clinically applicable. Cellular labeling using mechanoporation can improve our understanding of in vivo biodistributions of therapeutic cells and ultimately improve long-term outcomes of therapeutic cell transplants.

[1]  T. Sulchek,et al.  Cell Mechanical and Physiological Behavior in the Regime of Rapid Mechanical Compressions that Lead to Cell Volume Change. , 2019, Small.

[2]  R. Burgkart,et al.  Tracking Stem Cell Implants in Cartilage Defects of Minipigs by Using Ferumoxytol-enhanced MRI. , 2019, Radiology.

[3]  Howard Bernstein,et al.  Cell engineering with microfluidic squeezing preserves functionality of primary immune cells in vivo , 2018, Proceedings of the National Academy of Sciences.

[4]  P. Qiu,et al.  Microfluidic generation of transient cell volume exchange for convectively driven intracellular delivery of large macromolecules. , 2018, Materials today.

[5]  Rui Guo,et al.  Non-invasive monitoring of in vivo hydrogel degradation and cartilage regeneration by multiparametric MR imaging , 2018, Theranostics.

[6]  H. Daldrup-Link,et al.  The Protein Corona around Nanoparticles Facilitates Stem Cell Labeling for Clinical MR Imaging. , 2017, Radiology.

[7]  C. Moorman,et al.  Adipose-Derived Stem Cell Transplant Technique for Degenerative Joint Disease , 2017, Arthroscopy techniques.

[8]  Shreyas S Vasanawala,et al.  Current and potential imaging applications of ferumoxytol for magnetic resonance imaging. , 2017, Kidney international.

[9]  James C. Weaver,et al.  High-throughput Nuclear Delivery and Rapid Expression of DNA via Mechanical and Electrical Cell-Membrane Disruption , 2017, Nature Biomedical Engineering.

[10]  A. Yamagishi,et al.  Mechanoporation of living cells for delivery of macromolecules using nanoneedle array. , 2016, Journal of bioscience and bioengineering.

[11]  U. Galderisi,et al.  Clinical Trials with Mesenchymal Stem Cells: An Update , 2016, Cell transplantation.

[12]  K. Jensen,et al.  Live-cell protein labelling with nanometre precision by cell squeezing , 2016, Nature Communications.

[13]  Deniz A. Bölükbas,et al.  FMN-Coated Fluorescent USPIO for Cell Labeling and Non-Invasive MR Imaging in Tissue Engineering , 2014, Theranostics.

[14]  H. Daldrup-Link,et al.  MR Imaging of Stem Cell Transplants in Arthritic Joints , 2014, Journal of stem cell research & therapy.

[15]  H. Daldrup-Link,et al.  Iron administration before stem cell harvest enables MR imaging tracking after transplantation. , 2013, Radiology.

[16]  John Yu,et al.  Tracking the engraftment and regenerative capabilities of transplanted lung stem cells using fluorescent nanodiamonds , 2013, Nature nanotechnology.

[17]  Z. Gu,et al.  Superparamagnetic Iron Oxide Nanoparticles as MRI contrast agents for Non-invasive Stem Cell Labeling and Tracking , 2013, Theranostics.

[18]  Koen Van Laere,et al.  18F-FDG Labeling of Mesenchymal Stem Cells and Multipotent Adult Progenitor Cells for PET Imaging: Effects on Ultrastructure and Differentiation Capacity , 2013, The Journal of Nuclear Medicine.

[19]  Yoji Sato,et al.  Tumorigenicity studies for human pluripotent stem cell-derived products. , 2013, Biological & pharmaceutical bulletin.

[20]  Robert Langer,et al.  A vector-free microfluidic platform for intracellular delivery , 2013, Proceedings of the National Academy of Sciences.

[21]  M. Wendland,et al.  Magnetic Resonance Imaging of Ferumoxide-Labeled Mesenchymal Stem Cells in Cartilage Defects: In Vitro and in Vivo Investigations , 2012, Molecular imaging.

[22]  Y. Liu,et al.  Can ultrasound enable efficient intracellular uptake of molecules? A retrospective literature review and analysis. , 2012, Ultrasound in medicine & biology.

[23]  Bo Yu,et al.  Nanochannel electroporation delivers precise amounts of biomolecules into living cells. , 2011, Nature nanotechnology.

[24]  A. Kausz,et al.  Plasma Pharmacokinetics of Two Consecutive Doses of Ferumoxytol in Healthy Subjects , 2010, Clinical pharmacology and therapeutics.

[25]  H. Motaln,et al.  Human mesenchymal stem cells and their use in cell‐based therapies , 2010, Cancer.

[26]  R. Pazdur,et al.  FDA report: Ferumoxytol for intravenous iron therapy in adult patients with chronic kidney disease , 2010, American journal of hematology.

[27]  Jacob T. Robinson,et al.  Vertical silicon nanowires as a universal platform for delivering biomolecules into living cells , 2010, Proceedings of the National Academy of Sciences.

[28]  S. Soenen,et al.  Assessing cytotoxicity of (iron oxide-based) nanoparticles: an overview of different methods exemplified with cationic magnetoliposomes. , 2009, Contrast media & molecular imaging.

[29]  J. Lotz,et al.  The influence of ferucarbotran on the chondrogenesis of human mesenchymal stem cells. , 2009, Contrast media & molecular imaging.

[30]  A. Kausz,et al.  Physicochemical properties of ferumoxytol, a new intravenous iron preparation , 2009, European journal of clinical investigation.

[31]  Florence Gazeau,et al.  Universal cell labelling with anionic magnetic nanoparticles. , 2008, Biomaterials.

[32]  Daniel M. Hallow,et al.  Shear‐induced intracellular loading of cells with molecules by controlled microfluidics , 2008, Biotechnology and bioengineering.

[33]  K. Landfester,et al.  Carboxylated Superparamagnetic Iron Oxide Particles Label Cells Intracellularly Without Transfection Agents , 2008, Molecular Imaging and Biology.

[34]  C. Claussen,et al.  Transferrin receptor upregulation: in vitro labeling of rat mesenchymal stem cells with superparamagnetic iron oxide. , 2007, Radiology.

[35]  Michael Jerosch-Herold,et al.  THE POTENTIAL OF FERUMOXYTOL NANOPARTICLE MAGNETIC RESONANCE IMAGING, PERFUSION, AND ANGIOGRAPHY IN CENTRAL NERVOUS SYSTEM MALIGNANCY: A PILOT STUDY , 2007, Neurosurgery.

[36]  Nico de Jong,et al.  Sonoporation from jetting cavitation bubbles. , 2006, Biophysical journal.

[37]  Philippe Robert,et al.  Recent advances in iron oxide nanocrystal technology for medical imaging. , 2006, Advanced drug delivery reviews.

[38]  Dong Soo Lee,et al.  Tissue distribution of 18F-FDG-labeled peripheral hematopoietic stem cells after intracoronary administration in patients with myocardial infarction. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[39]  Sanjiv S. Gambhir,et al.  In Vivo Visualization of Embryonic Stem Cell Survival, Proliferation, and Migration After Cardiac Delivery , 2006, Circulation.

[40]  B. Cheson,et al.  Positron-emission tomography and assessment of cancer therapy. , 2006, The New England journal of medicine.

[41]  A. Arbab,et al.  Labeling of cells with ferumoxides–protamine sulfate complexes does not inhibit function or differentiation capacity of hematopoietic or mesenchymal stem cells , 2005, NMR in biomedicine.

[42]  W. K. Bolton,et al.  Pharmacokinetic Study of Ferumoxytol: A New Iron Replacement Therapy in Normal Subjects and Hemodialysis Patients , 2005, American Journal of Nephrology.

[43]  Eric T Ahrens,et al.  In vivo imaging platform for tracking immunotherapeutic cells , 2005, Nature Biotechnology.

[44]  Brian K Rutt,et al.  Detection threshold of single SPIO‐labeled cells with FIESTA , 2005, Magnetic resonance in medicine.

[45]  Jeff W M Bulte,et al.  Feridex labeling of mesenchymal stem cells inhibits chondrogenesis but not adipogenesis or osteogenesis , 2004, NMR in biomedicine.

[46]  Heather Kalish,et al.  Efficient magnetic cell labeling with protamine sulfate complexed to ferumoxides for cellular MRI. , 2004, Blood.

[47]  Ernst J. Rummeny,et al.  Capacity of human monocytes to phagocytose approved iron oxide MR contrast agents in vitro , 2004, European Radiology.

[48]  Heather Kalish,et al.  Comparison of Transfection Agents in Forming Complexes with Ferumoxides, Cell Labeling Efficiency, and Cellular Viability , 2004, Molecular imaging.

[49]  P. Marmottant,et al.  Controlled vesicle deformation and lysis by single oscillating bubbles , 2003, Nature.

[50]  S. Zimmer,et al.  Transfection of mammalian cells with plasmid DNA by scrape loading and sonication loading. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[51]  E. Neumann,et al.  Gene transfer into mouse lyoma cells by electroporation in high electric fields. , 1982, The EMBO journal.

[52]  Mario R. Capecchi,et al.  High efficiency transformation by direct microinjection of DNA into cultured mammalian cells , 1980, Cell.

[53]  H. Daldrup-Link,et al.  Magnetic resonance imaging and tracking of stem cells. , 2013, Methods in molecular biology.

[54]  Chung-Yuan Mou,et al.  Bifunctional magnetic silica nanoparticles for highly efficient human stem cell labeling. , 2007, Nano letters.

[55]  P. Jendelová,et al.  In vivo tracking of stem cells in brain and spinal cord injury. , 2007, Progress in brain research.

[56]  D. Prockop,et al.  Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. , 2006, Cytotherapy.